Navigation Links
FDA Warns of Codeine Risk for Some Nursing Mothers
Date:8/18/2007

Some women metabolize the drug quickly, raising chance of morphine overdose for baby

FRIDAY, Aug. 17 (HealthDay News) -- Nursing mothers who use medicines containing codeine and metabolize the drug quickly may be putting their baby at risk of a morphine overdose, U.S. health officials said Friday.

The U.S. Food and Drug Administration's warning was prompted by a report of the death of a 13-day-old breast-fed infant who died from morphine overdose. In that case, researchers found abnormally high morphine levels in the milk of the mother, who had been taking codeine to treat pain from an episiotomy. A genetic test found that the mother was an "ultra-rapid metabolizer" of codeine.

"Infants of nursing mothers who are taking codeine can have an increased risk of morphine overdose if the mother is an ultra-rapid metabolizer of codeine," Dr. Sandra Kweder, deputy director of the FDA's Office of New Drugs at the Center for Drug Evaluation and Research, said during a teleconference.

These women are genetically predisposed to metabolize codeine more rapidly and completely than other people, Kweder said. The pain-relieving effect of codeine occurs as some of it is metabolized into morphine, she explained.

Codeine is found in prescription and non-prescription medicines and used to relieve pain or treat cough. "Its use to manage pain after delivery is very common," Kweder said.

Ultra-rapid metabolizers of codeine are likely to have higher levels of morphine in their blood after taking usual doses of the drug, Kweder said. "Nursing mothers who are ultra-rapid metabolizers may also have higher morphine levels in their breast milk," she said. "These higher levels of morphine can affect the baby and lead to very severe, even life-threatening side effects in nursing babies."

Kweder advised doctors who prescribe codeine to nursing mothers to prescribe the lowest dose for the shortest amount of time. Doctors should also tell women how to recognize the signs of high morphine levels in themselves and their babies, she said.

Nursing mothers taking codeine should call their doctor if they become sleepy to the point of having difficulty taking care of the baby, Kweder advised.

As for symptoms of morphine overdose in babies, they include "signs of increased sleepiness, difficulty breast-feeding and especially breathing difficulties, or limpness," Kweder said. The mother should call the doctor immediately, she said, adding that if the doctor can't be reached, the "baby should be taken to an emergency room right away."

People who are ultra-rapid metabolizers of codeine usually don't know it, Kweder said. The number of people who are ultra-rapid metabolizers varies widely among different groups of people.

Among whites, 1 percent to 10 percent have the genetic potential. For blacks, it's about 3 percent, and for Hispanics and Asians, it's about 1 percent. But, for North Africans, Ethiopians and Saudi Arabians, the prevalence is between 16 percent and 28 percent, she said.

"The only way to know you are an ultra-rapid metabolizer is with a genetic test," Kweder said. There is an FDA-approved test that is widely available. "But our message is that while the test is widely available, it can be useful, but it is not a substitute for a doctor's judgment," she said.

While codeine products are safe for most people, the FDA asks that manufacturers of products containing codeine -- both prescription and over-the-counter -- add information to the label about the phenomenon of codeine ultra-rapid metabolism, especially as it relates to breast-feeding.

More information

For more on codeine, visit the U.S. Library of Medicine.



SOURCE: Aug. 17, 2007, teleconference with Sandra Kweder, M.D., deputy director, Office of New Drugs, Center for Drug Evaluation and Research, U.S. Food and Drug Administration


'/>"/>

Copyright©2007 ScoutNews,LLC.

Related medicine news :

1. International community warns India on HIV situation
2. Thakur warns doctors
3. Paracetamol May Cause Live Damage Warns Consumer Education and Research Centre
4. Study Warns About The Use Of Popular Asthma Drug To Stop Childrens Coughs
5. Indian Government warns Gujarat regarding possibility of bird flu
6. ADB Report Warns of Bird-Flu Catastrophe
7. FDA Warns Against Birth-Control Patch
8. Charlotte Church Warns kiss n tell girls not to flirt with Henson
9. UK Committee Warns on Food Shortages Due to Flu Epidemic
10. NHS Audit Commission Warns Possible Financial Collapse In Sussex And Surrey
11. Russia warns against travel to Turkey, Iran closes border
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/20/2017)... ... ... Angel”: a heartwarming and earnest tale of faith and believing in the path ... the creation of published author, Marjorie Lund-Fontaine, a former professional violinist, alumnus of The ... of her new book, Marjorie says, “‘The Angel’ was written as a fairytale, but ...
(Date:1/20/2017)... ... ... “Christmas in Suffolk”: a story of love, secrets, and mystery. “Christmas in ... where she works in a daycare and looks for inspiration in the local coffee ... Publishing, Sara Seymour’s new book is an adventure of love and secrets. ...
(Date:1/20/2017)... ... January 20, 2017 , ... “God's Miracle Man: Against All Odds”: ... the creation of published author, Keith C. A. Tucker, son of Minister Delores Pinnock ... Outreach pastured by Reverend Mark Hardy , “While sitting up in bed, I felt ...
(Date:1/19/2017)... ... January 19, 2017 , ... Wells ... facility enhancement of their 503A compounding pharmacy located in Ocala, Florida. , ... physicians and patients throughout the United States for high-quality human anti-aging and ...
(Date:1/19/2017)... ... ... WhoHaha , a digital media company dedicated to creating and delivering female-centric, ... three-part video series that uses humor to highlight ways to improve heart health and ... For Good™ movement, which is designed to inspire all Americans to make small changes ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... 19, 2017 Incretin Mimetics/GLP-1 Agonists, SNDRIs, Lipase ... The global anti-obesity drugs market is expected to ... the forecast period and CAGR of 38.7% in the second half ... a CAGR of 32.8% from 2016 to 2027. The market is ... $24,063 million in 2027. ...
(Date:1/19/2017)... -- James Gilbart , ... 2):3-8; http://www.touchoncology.com/articles/optimising-clinical-outcomes-gastrointestinal-cancers-through-inhibiting-angiogenesis-and ...      ... in a supplement to European Oncology & Haematology ... by James Gilbart and Axel ...
(Date:1/19/2017)... ALTO, Calif. , Jan. 19, 2017   ... research, is excited to announce that the first ... Cancer Biology  (RP:CB) have been published in eLife ... this project represents the first practical evaluation of ... result in reproducible studies. Unlike other assessments of ...
Breaking Medicine Technology: